On Thursday, the FDA approved a new daily pill that lowers cholesterol, potentially decreasing the risk of adverse events such as heart attacks or strokes. Lipfendra, developed by the pharmaceutical company Merck, can significantly reduce LDL — a type of “bad” cholesterol that can increase the risk …
The Food and Drug Administration approved a daily pill on Thursday that can lower cholesterol levels far below what can be achieved with statins, the cheap cholesterol-reducing pills. The drug, enlicitide, whose brand name is Lipfendra, is made by the pharmaceutical company Merck.
Lipfendra can be taken in conjunction with or an alternative to statins, the most prescribed medication in the US Sign up for the Breaking News US newsletter email The drug giant Merck on Thursday announced it had received FDA approval for a daily pill that can be an alternative to statins for treat…
The federal Food and Drug Administration has approved a first-of-its-kind pill that sharply reduces artery-clogging cholesterol in people who remain at high risk of heart attacks despite taking statins. The pill, named enlicitide, will be sold under the name Lipfenrda.
Lipfendraw, a newly-approved pill that lowers cholesterol, is as effective and less expensive than similar, injectable drugs. Lower LDL cholesterol levels reduce the risk of heart disease and stroke.
WASHINGTON (AP) — The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol in a way that’s previously only been available with expensive, injectable drugs.
The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol in a way that's previously only been available with expensive, injectable drugs.
Pittsburgh doctors on Thursday hailed government approval of a highly effective anti-cholesterol pill that had previously been available only as an injection, but they cautioned that cheap, traditional statins are likely here to stay.
The FDA has approved a new daily cholesterol pill that works differently from popular statins and may deliver better results for some people. Dr. Corey Bradley, a cardiologist at Columbia University's Irving Medical Center, joins "CBS Evening News" to discuss.
The FDA has approved a pill form of a powerful class of medication that targets bad LDL cholesterol. Chief medical correspondent Dr. Jon LaPook explains.
Showing the first 25 of 27 headlines. ·
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
A New Non-Statin Cholesterol Pill Is on the Market | Since Then
